Stephen Barat - 31 Mar 2023 Form 4 Insider Report for HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ)

Role
Senior VP of Therapeutics
Signature
/s/ Shaun D. McMeans, Attorney-in-Fact
Issuer symbol
HTGMQ
Transactions as of
31 Mar 2023
Transactions value $
-$140
Form type
4
Filing time
07 Apr 2023, 16:16:01 UTC
Previous filing
10 Feb 2023
Next filing
09 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HTGMQ Common Stock Tax liability -$140 -52 -3.82% $2.7* 1,309 31 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on November 9, 2021.